Vidal K, Allen P M
Center for Immunology, Washington University School of Medicine, St Louis, MO 63119, USA.
Semin Immunol. 1996 Apr;8(2):117-22. doi: 10.1006/smim.1996.0014.
Numerous studies have shown that a T cell can productively interact through its TCR with less-than-optimal ligands resulting in partial T-cell activation. These ligands, that we called 'altered peptide ligands' (APLs), can act as partial agonists, antagonists or weak agonists for the T cells. Here we discuss the self-antigen system that we used to provide evidence that endogenous APLs exist in vivo and affect T-cell development. We also report the ability of endogenous APLs to induce partial T-cell activation of peripheral T cells, and describe in which circumstances this could occur in vivo.
大量研究表明,T细胞可通过其TCR与次优配体进行有效相互作用,从而导致T细胞部分激活。这些配体,我们称之为“改变的肽配体”(APL),可作为T细胞的部分激动剂、拮抗剂或弱激动剂。在此,我们讨论我们用于提供体内存在内源性APL并影响T细胞发育证据的自身抗原系统。我们还报告了内源性APL诱导外周T细胞部分激活的能力,并描述了这种情况在体内可能发生的情形。